stockrow
Saturday 14 November 2026
Export NHTC’s income statement to Excel — free account
Natural Health Trends Corp.
NHTCConsumer Cyclical Internet Retail
Natural Health Trends Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.8 million, down 7.42% from fiscal 2024.
- Revenue
- −20.2%
- EPS
- +32.5%
- Free cash flow
- −1,670.0%
Quarter to September 2026, against a year earlier
0.75
0.02
+2.74%
Follow NHTC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.89 | 0.74 | 0.42 | 0.26 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(37.04) | (35.51) | (11.13) | (8.09) | |
P/B ratio |
1.52 | 1.72 | 1.00 | 0.59 | |
Price to Tangible BV |
1.64 | 1.93 | 1.13 | 0.67 | |
EV/Sales |
0.17 | 0.18 | (0.10) | (0.26) | |
EV/EBITDA |
0.00 | 0.00 | 1.59 | 4.51 | |
EV/Operating CF |
(1.11) | (0.97) | 1.14 | 2.08 | |
EV/FCF |
(1.10) | (0.95) | 0.98 | 1.88 | |
Quick Ratio |
2.11 | 1.60 | 1.56 | 1.70 | |
Current Ratio |
2.50 | 2.00 | 1.99 | 2.13 | |
Net Debt/EBITDA |
47.10 | 45.86 | 30.04 | 72.37 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.85 | 0.90 | 0.97 | 0.98 | |
Operating CF/Net income |
1.63 | 5.18 | 3.02 | 4.71 | |
Capex/Depreciation |
(0.23) | (10.45) | (14.13) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.13% | 38.28% | 42.79% | 41.97% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.30% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.54 | 0.39 | 0.64 | 1.10 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.55%) | (3.72%) | (8.77%) | (13.81%) | |
Free Cash Flow Yield |
(17.07%) | (26.31%) | (23.02%) | (52.79%) | |
Revenue per Share |
0.85 | 0.91 | 0.89 | 0.88 | |
Operating CF per Share |
(0.08) | (0.08) | (0.16) | (0.13) | |
Capex per Share |
0.00 | (0.01) | (0.04) | 0.00 | |
Free Cash Flow per Share |
(0.08) | (0.09) | (0.20) | (0.13) | |
Cash per Share |
2.51 | 2.09 | 2.17 | 2.05 | |
Shareholders Equity per Share |
2.04 | 1.62 | 1.77 | 1.75 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.04 | 1.62 | 1.77 | 1.75 | |
Free Cash Flow |
(0.96) | (0.91) | (1.69) | (1.10) | |
Working Capital |
20.51 | 13.29 | 11.77 | 11.63 | |
Capital Expenditures |
0.00 | (0.11) | (0.32) | (0.01) | |
Net Current Asset Value |
19.20 | 11.05 | 9.70 | 9.70 | |
EV/EBIT |
0.00 | 0.00 | 1.53 | 4.31 | |
Capex to Sales |
0.00 | 0.01 | 0.04 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
0.73 | 1.14 | 0.96 | 1.11 | |
Average Inventory |
2.66 | 2.39 | 2.41 | 2.10 | |
Average Assets |
46.89 | 42.56 | 37.19 | 34.76 | |
Average Common Equity |
28.15 | 23.67 | 22.03 | 20.58 |
Columns are period end dates · fundamentals updated 2 Nov 2026